文献速递认知障碍与痴呆脑血管病

非动脉炎性前部缺血性视神经病变与痴呆风险:一项全国性队列研究

Nonarteritic Anterior Ischemic Optic Neuropathy and the Risk of Dementia: A Nationwide Cohort Study.
PubMed 文献 · Neurology · 2024-07-15

该研究基于韩国国民健康保险服务数据库,纳入2010至2017年新诊断的非动脉炎性前部缺血性视神经病变患者42,943例及年龄性别匹配对照214,715例,回顾性分析显示NAION与全因痴呆、阿尔茨海默病、血管性痴呆及其他痴呆风险升高相关,且在年轻组和当前吸烟者中关联更强。

要点

  • NAION患者全因痴呆风险升高(HR 1.28,95%CI 1.20-1.36)。
  • NAION与阿尔茨海默病(HR 1.27)、血管性痴呆(HR 1.31)及其他痴呆(HR 1.39)风险升高相关。
  • NAION与全因痴呆的关联在65岁以下组(HR 1.83)强于65岁及以上组(HR 1.23),交互作用P<0.001。

核心结论

  • 在韩国全国性队列中,即使调整生活方式、健康状况和人口学因素后,NAION仍与全因痴呆、阿尔茨海默病、血管性痴呆及其他痴呆风险升高显著相关。
  • 研究提示血管病理在痴呆进展中可能发挥作用,NAION可能作为痴呆的强预测因子,并强调对NAION患者进行全面神经科评估的必要性。
  • 需要进一步研究以明确NAION与痴呆风险之间的关联。

研究设计与样本

  • 韩国全国性、基于人群的回顾性队列研究,数据来自韩国国民健康保险服务数据库。
  • 2010至2017年新诊断NAION患者42,943例,以及年龄和性别匹配的无NAION对照214,715例(平均年龄61.37岁±10.75 SD,女性55.48%)。
  • 主要结局为新的痴呆诊断,由新的ICD-10索赔记录联合抗痴呆药物处方确认。
  • 经过1年滞后观察期后,平均随访2.69年,使用风险比(HR)及95%CI评估痴呆风险。

主要发现

  • NAION患者全因痴呆风险升高(HR 1.28,95%CI 1.20-1.36)。
  • NAION患者阿尔茨海默病风险升高(HR 1.27,95%CI 1.18-1.36)。
  • NAION患者血管性痴呆风险升高(HR 1.31,95%CI 1.09-1.58)。
  • NAION患者其他痴呆风险升高(HR 1.39,95%CI 1.11-1.73)。
  • 亚组分析中,NAION与全因痴呆的关联在年轻组更强(65岁以下HR 1.83 vs 65岁及以上HR 1.23;交互作用P<0.001);NAION与全因痴呆及血管性痴呆的关联在当前吸烟者中尤其强。

临床怎么用

  • 作者认为NAION可能作为痴呆的强预测因子,强调对NAION患者进行全面神经科评估的必要性。

局限性

  • 需要进一步研究以明确NAION与痴呆风险之间的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: While emerging theories suggest that vascular dysfunction may occur concurrently with the amyloid cascade in Alzheimer disease (AD) pathogenesis, the role of vascular components as primary neurodegeneration triggers remains uncertain. The aim of this retrospective, population-based cohort study conducted in Korea was to explore the link between nonarteritic anterior ischemic optic neuropathy (NAION) and dementia risk. METHODS: In this nationwide, population-based, retrospective cohort study, we identified newly diagnosed NAION from 2010 to 2017 in the Korean National Health Insurance Service database. The primary outcome was new dementia diagnoses confirmed by new ICD-10 claims coupled with antidementia medication prescriptions. We assessed dementia risk using hazard ratios (HRs) with 95% CIs over an average 2.69-year follow-up after a 1-year lag period. RESULTS: The cohort consisted of 42,943 patients with NAION and 214,715 age-matched and sex-matched controls without NAION (mean age 61.37 years ± 10.75 SD, 55.48% female). The study found a higher risk of all-cause dementia (ACD; HR 1.28, 95% CI 1.20-1.36), AD (HR 1.27, 95% CI 1.18-1.36), vascular dementia (VaD; HR 1.31, 95% CI 1.09-1.58), and other dementia (HR 1.39, 95% CI 1.11-1.73) among patients with NAION, regardless of other potential confounding factors such as age, sex, lifestyle behaviors, economic status, and preexisting health conditions. In subgroup analysis, the associations between NAION and ACD were stronger in the younger age group (HR 1.83 for those younger than 65 years vs 1.23 for those 65 years or older; p for interaction <0.001). Moreover, the association of NAION with both ACD and VaD was particularly strong among current smokers. DISCUSSION: We found a significant association between NAION and increased risk for ACD, AD, VaD, and other dementia even after adjusting for potential confounders such as lifestyle, health conditions, and demographic factors within a nationwide cohort. This study highlights the potential role of vascular pathology in dementia progression and suggests that NAION may serve as a robust predictor for dementia, highlighting the need for comprehensive neurologic assessment in patients with NAION. Further research is needed to clarify the association between NAION and dementia risk.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kim J, Han K, Jung JH, et al. Nonarteritic Anterior Ischemic Optic Neuropathy and the Risk of Dementia: A Nationwide Cohort Study. Neurology. 2024. PMID: 39008797. doi:10.1212/WNL.0000000000209657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。